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Introduction
The Ministry of Health annual report in 1996 ranked
malignancy as the sixth most common cause of
mortality among hospitalized patients!. Among all
malignant neoplasm in Malaysia, lung cancer is the
most common type of malignancy occurring in males
whilst in female it ranks as the fourth commonest'. The
incidence of lung cancer in Malaysia is unknown but
annual incidence of all cancers has been estimated to
be around 30,0003. The number for newly diagnosed
lung cancer is expected to rise, as the prevalence of
smokers among adult population is rising'.
In the United States, the majority of patients with lung
cancer present quite late in the course of the diseases
and this scenario is similar in Malaysia6• The most usual
mode ofestablishing the diagnosis of lung cancer is by
means of bronchoscopy. During bronchoscopy, the
usual abnormal bronchoscpic findings include finding
an obvious endobronchial mass or irregular musosa
with narrowing of the bronchi. In addition, specimens
can be obtained for histopathological or cytological
examinations to confirm diagnosis and plan treatment.
The bronchoscopist usually performs endobronchial
biopsies (EB), transbronchial biopsies (TBB), bronchial
brushings (BB) or bronchial washings (BW) depending
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on the bronchoscopic findings to increase the yield for
diagnosis of cancer. In the presence of an
endobronchial mass during bronchoscopy, the
sensitivity of EB, .BB and BW together in diagnosing
lung cancer is in excess of 90%7. When lesions are
visible at bronchoscopy, the additional yield from
cytological specimens in forms of· BB and BW vary
between 5%8 and 13%9,10.
When endoscopic findings consisted of only abnormal
mucosa or extraluminal bronchial narrowing with no
mass lesions, the yield from cytological specimens has
been found to be around 35'W,1O whether or not
fluoroscopy was used during bronchoscopy.
Bronchoscopy is costly as it involves labour in terms of
specimen collection and other related processes and
also materials involved during the procedure. We are
not aware of any local audit of these procedures. In
this study we evaluated the value of cytological
specimens from bronchial brushings and washings in
addition to forceps biopsies (endobronchial and
transbronchial) during bronchoscopy for investigation
of lung cancer in a chest clinic of a general hospital in
Malaysia. We evaluated all our bronchoscopy data
retrospectively to find out whether our cytological
specimens from BW and BB in addition to forceps
biopsies (EB and TBB) significantly increased the
number of positive results from bronchoscopy during
investigation for lung cancer.
Materials and Methods
This was a retrospective study of all bronchoscopy
records for investigation of lung cancer in the chest unit
of Hospital Sultanah Aminah (HSA), Johor Bahru
between January 1997 and December 1999. The chest
clinic of HSA serves a population of nearly two and a
half million people in the southern region of Malaysia.
There is also a cardio-thoracic department adjacent to
the chest clinic for thoracic surgery input. Inclusion
criteria were bronchoscopy findings of obvious as
endobronchial mass (Group A) and abnormal mucosa
and/or bronchial narrowing when a mass was not seen
(Group B). The majority of cases in Group B had
contact bleeding. Bronchoscopy cases with other
findings were excluded. Once cases were identified,
the case notes were retrieved from the chest clinic to
record the final histological or cytological diagnosis for
lung cancer and the methods of arriving at the
diagnosis if the bronchoscopy specimens were negative
for lung cancer. Cases of repeat bronchoscopy were
excluded. Bronchoscopy at our chest clinic was done
730
using Olympus CLE-4E. There were two physicians
performing bronchoscopy on regular basis and were
responsible for performing all the cases under study.
Bronchial brushings were performed using 47R
Olympus brush and biopsy using FB21 Olympus
SX/C/K-l. On average, 40ml of 1% lignocaine was used
during each bronchoscopy procedure with two nurses
assisting, mainly for specimen collection. Patients
undergoing bronchoscopy received oral midazolam (on
average 7.5mg) and an intra-muscular injection of
atropine (600 microgram) half an hour before the
procedure. Pulse oximetry was used to monitor
cutaneous oxygen saturation throughout the procedure,
BW specimens (average of 3) were collected using 20-
30ml normal saline aspirated through the
bronchoscope into collecting bottles. BB were
smeared onto glass slides (average of 3) and preserved
in 95% ethyl alcohol. During the biopsy procedure, an
average of 3 samples were also taken for either TBB or
EB. These specimens were preserved in the same way
and sent to pathology laboratory located one floor
above the chest clinic after the procedure. The standard
practice in our clinic was to perform EB, BB and BW
on all bronchoscopy cases with findings as in Group A
and TBB, BB and BW for cases in Group B. Statistical
analysis was done using McNemar's test for matched
group analysis and P value of less than 0.05 is
considered significant.
Results
A total of 495 bronchoscopies were performed between
January 1997 and December 1999 of which 437 (88%)
were done to investigate lung cancer (Figure 1). Two
hundred and thirty-six (54%) bonchoscopy cases were
included in the study. There were 177 cases in Group
A and 59 cases included in Group B. Figure 1 shows
the number of cases classified as Group A and B,
including the number of cases excluded.
The indication for bronchoscopy in both groups was
mainly abnormal chest x-ray (OCR) findings. Table I
shows the indication for bronchoscopy by CXR
appearances in cases from both groups.
All cases in Group A underwent EB, BB and BW.
Positive histological diagnosis for cancer was obtained
in 151 specimens of EB (85.3%). There was only one
additional increase in the number of positive cases
when BB was combined with EB. The percentage of
positive results for cancer however increased to 88.1%
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when EB was combined with both BB and BW (85.3%
vs 88.1%, McNemar's, p=0.06). Table II summarises the
details of all results in Group A and Group B. Twenty-
one cases had negative results from all three
specimens, EB, BB and BW. Twelve of these
underwent repeat bronchoscopy with the results of
repeat EB were all positive for cancer and 9 had fine
needle aspiration cytology (FNAC) of palpable
supraclavicular or cervical lymph node that confirmed
metastatic lung cancer. Table III summarises these
results.
All 59 patients in Group B underwent TBB, BW and BB
during bronchoscope and TBB yielded 22 (37.3%)
positive results for cancer. TBB and BB together
marginally increased. the number of positive results to
40.7% but when all three specimens of TBB, BB and
BW were combined, the number of positive results
significantly rose to 32 (37.3% vs 54.2%, McNemar's,
P=0.002), an additional increase of 16.9% (Table II).
Table III summarises the investigations performed to
confirm the presence of malignancy in those with
negative bronchoscopy results (n=27) from Group B.
Table IV shows all the types of cancer diagnosed in
cases from Group A and B.
Table I: Indication for bronchoscopy by CXR appearances in both groups
Type of appearance
Mass lession on CXR"
Pleural effusion
Partial lung collapse on CXR
Persistent consolidation on CXR
Group A Group B
1W ~
27 24
33 4
10 2
CXR is posterior-anterior cheast readiograph.
"Mass lession could be single or multiple with hilar or mediastinal enlargement
Table II: The yield of positive results for cancer from (EB/TBB), (BB) and (BW) in both
Group A and Group B
Specimen
EB!TBB"
EB!TBB" + BB
EB!TBB" + BW
EB/TBB" + BW
"Group A underwent EB and Group B Had TBB
CI stands for 95% confidence interval
Group A (%, {Cll n=l77 Group B (%, (CI}) n=59
151 (85.3, {79.90}) 22(37.3,{26,50})
152(85.9,{80,90}) 24(40.7,{29,54})
155(87.8,{82,92}) 30(50.8,{39,63})
156(88.1 ,{82 92}) 32(54.2,{41 66})
Table III: Methods to confirm malignancy in cases with negative bronchoscopy specimens from
Group A and Group B
gy p y p
All cases of repeat bronchoscopy had positive EB results for cancer.
CT stands for computerised tomography.
FNAC stands for fine neddle aspiration cytology.
Type Group A Group B
Repeat bronchoscopy 12
FNAC of lymph nodes" 9 4
Pleural biopsy 11
CT quided FNAC of lung mass 6
FNAC of Lymph nodes 4
Sputum cytology 3
Pleural fluid cytology 1
Thoracotomy 1
FANC skin nodules 1
Total 21 27
"L m)h nodes were mainl- su raclavicular nodes with 2 cases with nodes in the Iower cervical re Ion.
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Table IV: Lung cancer by types in both groups
Type Group A Group B
Squamous 53 20
Adenocarcinoma 49 17
Large cells 13 6
Small cell 33 12
Undifferentiated carcinoma 24 4
Adenosnuamous 5 0
Total 177 59
Figure 1.
Distribution of all bronchoscopy cases done within the study period. Fifty eight cases
were done for reasons other than investigation for lung cancer, while 437 cases were
done to investigate for lung cancer.
A tot~l of495 bronchoscopy
cases done*
58 cases done
for other
reasons**
437 cases to investigate
lung cancer.
201 cases excluded
based on
bronchoscopic
fmdings***
Group B (n=59)
732
* Total included 10 cases recorded in the bronchoscopy record but the notes were missing
**They were done for microbiological analysis (51), suspected sarcoidosis (4) and to rule
out extension ofoesophageal cancer into bronchus (3)
***The cases excluded were those without the findings of Group A or GroupB. The
findings were normal appearance (161) mucopurulent secretions (I 8) and bronchial
scarring (12)
Group A=endobronchial mass seen
Group B=abnormal mucosa and/or bronchial narrowing in absence ofmass lesion
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Discussion
This study has divided bronchoscopic findings in
.investigation for lung cancer into two groups. Group
A represents visualization of obvious endobronchial
mass. Endobronchial biopsies in this group of cases
are highly rewarding in that the percentage of positive
results from biopsy alone approach 90'W. Additional
yield from cytological specimens from washing and
brushings however are quite variable"' 9,10.
Our study shows that this is also the case in a local
chest unit that offers regular bronchoscopy service. The
yield of positive results for cancer from EB at our unit
is 85.3% and this is comparable to other studies8•9• The
additional yield from cytology from both BB and BW in
our study is only 2.8%. Combination of biopsy and
cytology (BB and BW) therefore did not significantly
increase (85.3% vs 88.1%, McNemar's, p=0.06) the
number of positive results undergoing bronchoscopy
for investigation of lung cancer. A recent study by
Chittoock et al" has also confirmed that routine
cytological specimen collection in this group of cases
has low additional positive yield and is not cost
effective. We therefore feel that routine cytological
specimen collection (BB and BW) in cases of visible
endobronchial lesions during bronchoscopy has low
additional value and should be discouraged.
Our study has also looked at another group of cases
with no obvious mass lesion but with mucosal
abnormalities or evidence of bronchial narrowing or
both. Our results show that the yield for TBB alone
was 37.3%. The addition of BB to TBB increased the
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yield by 2 cases to 40.7%. When BWwas included, the
yield increased significantly to 54.2% (37.3% vs 54.2%,
McNemar's, P=0.002). Our results show that there is a
significant increase in the number of positive results
when cytology specimens (BW and BB) were
combined with TBB by 16.9%. This finding is lower
than results from other studies (Govert et al 1996) and
13% (Mak VHF et al 1996, Lam YK et al 1983) 8. 9 that
had looked at cases similar to ours in Group B but the
study by Lam et al8 however had used fluoroscopy to
guide bronchoscopy. We are unable to explain why our
figure is slightly low. A recent article (Chechani V
1996) 12 revealed an overall diagnostic rate of 80% for
non-endoscopically tumor by bronchoscopy under
biplane fluoroscopy screening. Our chest unit does not
have such facility and we performed bronchoscopy
without the guidance of fluoroscopy in all our cases.
Nevertheless, our results show significant advantage in
adding cytology specimens to TBB when lesions as in
cases in Group B were present. We therefore advocate
routine collection of cytology specimens by BW
especially and BB in addition to TBB when lesions
such as our cases were present. In places where
fluoroscopy service was available, this should be used
to increase the overall yield from bronchoscopy. In
conclusion, our study shows that when endobronchial
mass was present during bronchoscopy, cytological
specimens in addition to EB did not significantly
increase the number of positive results for cancer.
When lesions were not visible except for abnormal
mucosa or bronchial compression or both, cytology
specimens significantly increased the yield for
diagnosis of lung cancer.
Fill
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